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1. Introduction 
The concept of nonclassical antimetabolites [l] 
allows for major structural changes of enzyme inhib- 
itors at that part of the molecule which does not 
directly interfere with its binding to a specific site of 
the protein. This idea has led to the evaluation of 
active-site-directed irreversible inhibitors bearing 
functional groups that might form covalent bonds to 
reactive residues within the enzyme [2]. Specificity 
of this irreversible desactivation requires the forma- 
tion of a reversible enzyme-inhibitor complex prior 
to the chemical reaction. 
It has become clear from previous studies [3,4] 
that thymidine kinase (ATP-thymidine 5’-phospho- 
transferase; EC 2.7.1.21) from E. coli exhibits bulk 
tolerance towards substitution at {he 5’-position of its 
substrate thymidine. We have extended these investi- 
gations, and wish to report on the irreversible interac- 
tion between thymidine kinase and several 5’-deriva- 
’ tives of thymidine and its analogs. 
2. Materials and methods 
2.1. Preparation of thymidine kinase 
The enzyme was purified from crude extracts of 
E. coli by salt precipitation (O-4.5% ammonium sulfate 
saturation) and affinity chromatography on Sepharose 
to which 6_O?-amino) benzyluracil was attached cova- 
lently [S] . From analysis on denaturing polyacryl- 
amide gels, enzyme purity was estimated at 18%; the 
specific activity was determined to be 1103 units/mg 
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protein. Enzyme preparations obtained by this proce- 
dure were essentially free of esterase activity as fol- 
lowed by the hydrolysis of p-nitrophenylacetate. 
2.2. Synthesis of thymidine derivatives 
Synthesis has been described in detail for 4-thio- 
thymidine [6], 5’-amino-5’-deoxythymidine [7], and 
its N-bromoacetyl derivative [8]. Sulfonylfluoride- 
substituted derivatives were obtained by reacting 
the nucleosides with 0-, m- and p-fluorosulfonyl- 
substituted benzenesulfonyl chlorides in anhydrous 
pyridine at -20°C [9]. Compounds were characterized 
by elemental analysis and spectroscopic data. The 
5’-chloro-,-bromo- and Godoacetic acid esters of thymi- 
dine were kindly provided by Dr J. P. Neenan. 
3. Results 
Following previous observations that preincubation 
of thymidine kinase from E. coli with 5- and 6-sub- 
stituted uracils carrying sulfonylfluoride and bromo- 
acetyl groups leads to a time- gnd concentration- 
dependent decrease of catalytic activity (W. Rohde, 
unpublished results), we have extended similar studies 
towards 5’-substituted thymidine and thymidine analogs. 
Figure 1 depicts a typical desactivation pattern when 
the enzyme is incubated in the presence of the m- and 
p-sulfonylfluorides III and IV, respectively. No loss of 
enzymatic activity is observed with the o-sulfonyl- 
fluoride II under these conditions. The N-bromoacetyl 
derivative I of 5’-amino-5’-deoxythymidine does not 
.desactivate the enzyme upon preincubation, nor do the 
5’-halogenacetyl esters of thymidine (data not shown). 
Desactivation rates are influenced by the presence 
of ligands interacting with the allosterically regulated 
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Fig.1. Time-dependent inactivation of thymidine kinase; 
20 enzyme units were incubated at 37°C in total vol. 0.1 ml, 
containing 50 mM Tris . HCI, pH 8.0, 10% DMSO and 0.5 mM 
of the corresponding thymidine derivatives I-IV. At the 
indicated time intervals, 10 ~1 samples were withdrawn and 
assayed for residual enzyme activity [5]. 
enzyme [lo] . Figure 2 shows that dCDP, an activator 
of enzyme activity that binds to a site distinct from 
the ATP- and thymidine-binding sites, brings about an 
increase of the apparent first-order rate constant kapp 
of desactivation. On the other side, the substrate thy- 
midine as well as ATP, the phosphate-donating cofactor 
of the enzymatic reaction, exhibit measurable protec- 
tive effects. This protection against desactivation 
becomes even more drastic with dTTP, the in vivo 
feedback inhibitor. In the presence of this allosteric 
and competitive inhibitor with regard to thymidine, 
irreversible inhibition is not observed during the time 
course followed. Similar effects on desactivation rates 
were obtained for the sulfonylfluorides III and IV. 
Thymidine kinase, preincubated with the 4-thio- 
thymidine derivative V until total loss of enzymatic 
activity and reisolated by gel fdtration on G-25 
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l 1 mp? ATP H 
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Fig.2. Effect of allosteric regulators on the inactivation of 
thymidine kinase by the 4-thiothymidine derivative V. 
Experimental conditions were the same as described for tig.1, 
except for the addition of the indicated ligands. 
Sephadex, shows a decrease of the A&As30 ratio. 
This reflects the covalent attachment of this inhibitor 
with the characteristic 4-thiothymidine chromophor 
@max 330 nm, E 20 000). 
With enzyme preparations obtained by different 
purification procedures [3], desactivation of thy 
midine kinase levels off rapidly. This was shown to be 
due to the presence of esterases which compete for 
sulfonylfluorides by covalent bond formation via the 
SOsF moiety. When, e.g., a-chymotrypsin (9 X 10e6 M) 
is preincubated with inhibitor III at concentrations of 
1,2.5 and 5 X 10T4 M, enzyme activity decreases with 
tr/s of 6.6, 2.4 and 0.83 min, respectively. This des- 
activation of the protease resembles its interaction 
with phenylmethyl sulfonylfluoride which forms a 
covalent bond to the active site-specific serine 195 
[l l] . In contrast, thymidine kinase is not inactivated 
by phenylmethyl sulfonylfluoride. 
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4. Discussion 
Several thymidine derivatives have been evaluated 
as irreversible inhibitors of thymidine kinase from 
E. coli. The m- and p-fluorosulfonylsubstituted thy- 
midine derivatives III, IV, and V irreversibly interact 
with the enzyme, presumably because of juxta- 
positioning of the SOZF moiety and a reactive amino 
acid residue close to the active site. The ortho deriva- 
tive II does not decrease catalytic activity, nor does 
the structurally unrelated phenylmethyl sulfonyl- 
fluoride act as an irreversible inhibitor. Together with 
the finding that allosteric regulators of enzyme activity 
influence the desactivation pattern, it seems reasonable 
to assume that interaction of these thymidine deriva- 
tives with the enzyme is a specific process. Clearly, 
detailed kinetic data are necessary to decide unequivo- 
cally whether these compounds might serve as affinity 
labeling reagents. 
The use of 4-thiothymidine derivatives provides an 
opportunity for spectroscopic studies on enzyme- 
inhibitor interaction. Furthermore, 4-thiothymidine 
readily exchanges with elemental 35S [ 12 ] ; the 35S- 
labeled compound V might thus serve to identify the 
amino acid residue involved in covalent bond forma- 
tion. The role which thymidine kinase might play in 
DNA regulation [ 131 stresses the importance of 
specific and possibly irreversible inhibitors of this 
enzyme. It is clear, however, from our data that sul- 
fonylfluorides because of their interaction with the 
ubiquitous esterases do not serve this purpose. 
Acknowledgement 
The author is a recipient of a fellowship by the 
Deutsche Forschungsgemeinschaft. 
References 
111 
121 
131 
[41 
[51 
[61 
[71 
181 
[91 
[lOI 
IllI 
[I21 
[I31 
Baker, B. R. (1959) Cancer Chemother. Rep. No. 4, I- 10. 
Baker, B. R. (1967) in: Design of Active-Site-Directed 
Irreversible Enzyme Inhibitors, John Wiley and Sons, 
New York. 
Rohde, W. and Lezius, A. G. (1971) Hoppe-Seyler’s 
Z. Physiol. Chem. 352,1507-1516. 
Baker, B. R. and Neenan, J. P. (1972) J. Med. Chem. 
15,940-944. 
Rohde, W. (1977) Anal. Biochem. 80,643-645. 
Scheit, K. H. (1968) Chem. Ber. 101, 1141-1147. 
Horwitz, J. P., Tomson, A. J., Urbanski, J. A. and Chua, J. 
(1962) J. Org. Chem. 27, 3045-3048. 
Neenan, J. P. and Rohde, W. (1973) J. Med. Chem. 16, 
580-581. 
Reist, E. J., Benitez, A. and Goodman, L. (1964) J. Org. 
Chem. 29,554-558. 
Okazaki, R. and Kornberg, A. (1964) J. Biol. Chem. 
239,275-284. 
Cardinaud, R. and Baker, B. R. (1970) J. Med. Chem. 
13,467-470. 
Moravek, J. and Kopecky, J. J. (1969) Coll. Czech. 
Chem. Commun. 34,4013-4018. 
Blakeley, R. L. and Vitols, E. (1968) Annu. Rev. Bio- 
them. 37,201-224. 
120 
